+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Allergy Immunotherapy Market Research Report by Type (SCIT and SLIT), Allergy Type, Distribution Channel, State - United States Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 121 Pages
  • July 2022
  • Region: United States
  • 360iResearch™
  • ID: 5121610
UP TO OFF until Dec 31st 2022
The United States Allergy Immunotherapy Market size was estimated at USD 776.26 million in 2021, USD 884.08 million in 2022, and is projected to grow at a CAGR 10.33% to reach USD 1,400.38 million by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Allergy Immunotherapy to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Type, the market was studied across SCIT and SLIT.
  • Based on Allergy Type, the market was studied across Allergic Rhinitis, Asthma, Food Allergy, and Venom Allergy.
  • Based on Distribution Channel, the market was studied across Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy and Drug Stores.
  • Based on State, the market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Allergy Immunotherapy market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Allergy Immunotherapy Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Allergy Immunotherapy Market, including Adamis Pharmaceuticals Corporation, Aimmune Therapeutics, Inc, ALK, ALK-Abelló A/S, Allergy Therapeutics, Allovate, LLC, Anergis SA, ASIT Biotech SA, Biomay AG, Circassia, DBV Technologies SA, DESENTUM OY, HAL Allergy B.V., HollisterStier Allergy, Inimmune Corporation, Jubilant Life Sciences Ltd, LETIPharma GmBH, Merck KGaA, Mylan N.V., Sandoz, Stallergenes Greer PLC, and Torii Pharmaceutical Co. Ltd..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the United States Allergy Immunotherapy Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Allergy Immunotherapy Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Allergy Immunotherapy Market?
4. What is the competitive strategic window for opportunities in the United States Allergy Immunotherapy Market?
5. What are the technology trends and regulatory frameworks in the United States Allergy Immunotherapy Market?
6. What is the market share of the leading vendors in the United States Allergy Immunotherapy Market?
7. What modes and strategic moves are considered suitable for entering the United States Allergy Immunotherapy Market?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19
6. Allergy Immunotherapy Market, by Type
6.1. Introduction
6.2. SCIT
6.3. SLIT
7. Allergy Immunotherapy Market, by Allergy Type
7.1. Introduction
7.2. Allergic Rhinitis
7.3. Asthma
7.4. Food Allergy
7.5. Venom Allergy
8. Allergy Immunotherapy Market, by Distribution Channel
8.1. Introduction
8.2. Hospital Pharmacy
8.3. Online Pharmacy
8.4. Retail Pharmacy and Drug Stores
9. California Allergy Immunotherapy Market10. Florida Allergy Immunotherapy Market11. Illinois Allergy Immunotherapy Market12. New York Allergy Immunotherapy Market13. Ohio Allergy Immunotherapy Market14. Pennsylvania Allergy Immunotherapy Market15. Texas Allergy Immunotherapy Market
16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis
16.3. Market Share Analysis, By Key Player
16.4. Competitive Scenario
16.4.1. Merger & Acquisition
16.4.2. Agreement, Collaboration, & Partnership
16.4.3. New Product Launch & Enhancement
16.4.4. Investment & Funding
16.4.5. Award, Recognition, & Expansion
17. Company Usability Profiles
17.1. Adamis Pharmaceuticals Corporation
17.2. Aimmune Therapeutics, Inc
17.3. ALK
17.4. ALK-Abelló A/S
17.5. Allergy Therapeutics
17.6. Allovate, LLC
17.7. Anergis SA
17.8. ASIT Biotech SA
17.9. Biomay AG
17.10. Circassia
17.11. DBV Technologies SA
17.12. DESENTUM OY
17.13. HAL Allergy B.V.
17.14. HollisterStier Allergy
17.15. Inimmune Corporation
17.16. Jubilant Life Sciences Ltd
17.17. LETIPharma GmBH
17.18. Merck KGaA
17.19. Mylan N.V.
17.20. Sandoz
17.21. Stallergenes Greer PLC
17.22. Torii Pharmaceutical Co. Ltd.
18. Appendix
18.1. Discussion Guide
18.2. License & Pricing
List of Figures
FIGURE 1. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, 2021 VS 2027 (USD MILLION)
FIGURE 3. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 4. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 5. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY STATE, 2027
FIGURE 7. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET DYNAMICS
FIGURE 8. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2021 VS 2027 (%)
FIGURE 9. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2027
FIGURE 11. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY SCIT, 2019-2027 (USD MILLION)
FIGURE 12. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY SCIT, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 13. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY SLIT, 2019-2027 (USD MILLION)
FIGURE 14. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY SLIT, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 15. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2021 VS 2027 (%)
FIGURE 16. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2027
FIGURE 18. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGIC RHINITIS, 2019-2027 (USD MILLION)
FIGURE 19. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGIC RHINITIS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 20. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ASTHMA, 2019-2027 (USD MILLION)
FIGURE 21. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ASTHMA, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 22. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGY, 2019-2027 (USD MILLION)
FIGURE 23. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGY, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 24. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY VENOM ALLERGY, 2019-2027 (USD MILLION)
FIGURE 25. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY VENOM ALLERGY, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 26. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2021 VS 2027 (%)
FIGURE 27. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2021 VS 2027 (USD MILLION)
FIGURE 28. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2027
FIGURE 29. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY HOSPITAL PHARMACY, 2019-2027 (USD MILLION)
FIGURE 30. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY HOSPITAL PHARMACY, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 31. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ONLINE PHARMACY, 2019-2027 (USD MILLION)
FIGURE 32. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ONLINE PHARMACY, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 33. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY RETAIL PHARMACY AND DRUG STORES, 2019-2027 (USD MILLION)
FIGURE 34. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY RETAIL PHARMACY AND DRUG STORES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 35. CALIFORNIA ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 36. FLORIDA ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 37. ILLINOIS ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 38. NEW YORK ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 39. OHIO ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 40. PENNSYLVANIA ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 41. TEXAS ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 42. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 43. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 44. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES ALLERGY IMMUNOTHERAPY MARKET, BY TYPE
List of Tables
TABLE 1. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 4. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 5. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY SCIT, BY STATE, 2019-2027 (USD MILLION)
TABLE 7. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY SLIT, BY STATE, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2019-2027 (USD MILLION)
TABLE 9. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGIC RHINITIS, BY STATE, 2019-2027 (USD MILLION)
TABLE 10. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ASTHMA, BY STATE, 2019-2027 (USD MILLION)
TABLE 11. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGY, BY STATE, 2019-2027 (USD MILLION)
TABLE 12. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY VENOM ALLERGY, BY STATE, 2019-2027 (USD MILLION)
TABLE 13. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 14. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY HOSPITAL PHARMACY, BY STATE, 2019-2027 (USD MILLION)
TABLE 15. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ONLINE PHARMACY, BY STATE, 2019-2027 (USD MILLION)
TABLE 16. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY RETAIL PHARMACY AND DRUG STORES, BY STATE, 2019-2027 (USD MILLION)
TABLE 17. CALIFORNIA ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 18. CALIFORNIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 19. CALIFORNIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2019-2027 (USD MILLION)
TABLE 20. CALIFORNIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 21. FLORIDA ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 22. FLORIDA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 23. FLORIDA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2019-2027 (USD MILLION)
TABLE 24. FLORIDA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 25. ILLINOIS ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 26. ILLINOIS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 27. ILLINOIS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2019-2027 (USD MILLION)
TABLE 28. ILLINOIS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 29. NEW YORK ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 30. NEW YORK ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 31. NEW YORK ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2019-2027 (USD MILLION)
TABLE 32. NEW YORK ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 33. OHIO ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 34. OHIO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 35. OHIO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2019-2027 (USD MILLION)
TABLE 36. OHIO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 37. PENNSYLVANIA ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 38. PENNSYLVANIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 39. PENNSYLVANIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2019-2027 (USD MILLION)
TABLE 40. PENNSYLVANIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 41. TEXAS ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 42. TEXAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 43. TEXAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2019-2027 (USD MILLION)
TABLE 44. TEXAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 45. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 46. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 47. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 48. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET RANKING
TABLE 49. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SHARE, BY KEY PLAYER, 2021
TABLE 50. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET MERGER & ACQUISITION
TABLE 51. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 52. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 53. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET INVESTMENT & FUNDING
TABLE 54. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 55. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET: LICENSE & PRICING

Companies Mentioned

  • Adamis Pharmaceuticals Corporation
  • Aimmune Therapeutics, Inc
  • ALK
  • ALK-Abelló A/S
  • Allergy Therapeutics
  • Allovate, LLC
  • Anergis SA
  • ASIT Biotech SA
  • Biomay AG
  • Circassia
  • DBV Technologies SA
  • DESENTUM OY
  • HAL Allergy B.V.
  • HollisterStier Allergy
  • Inimmune Corporation
  • Jubilant Life Sciences Ltd
  • LETIPharma GmBH
  • Merck KGaA
  • Mylan N.V.
  • Sandoz
  • Stallergenes Greer PLC
  • Torii Pharmaceutical Co. Ltd.

Methodology

Loading
LOADING...